Page last updated: 2024-09-03

astragaloside a and Blood Poisoning

astragaloside a has been researched along with Blood Poisoning in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's6 (85.71)2.80

Authors

AuthorsStudies
Tang, JL; Xin, M; Zhang, LC1
Chen, D; Feng, M; Guo, H; Lv, J; Su, L; Tu, Y; Wang, Z; Zhang, C1
Guo, L; Guo, Q; Huang, X; Ma, M; Su, Y; Yin, X1
Chen, R; Dai, H; Luo, J; Wang, Y; Zhan, C; Zheng, Y; Zhong, Y; Zhou, C1
Ding, L; Geng, L; Hu, X; Li, M; Wang, Z; Xie, S; Yang, T1
Guo, LH; Huang, X; Liu, B; Ma, SY; Yin, X; Zhang, MZ1
Jiang, H; Liu, R; Tian, Y; Wu, X; Zhao, W1

Other Studies

7 other study(ies) available for astragaloside a and Blood Poisoning

ArticleYear
Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury.
    Aging, 2022, Jul-20, Volume: 14, Issue:14

    Topics: Acute Kidney Injury; Astragalus propinquus; Humans; Lipopolysaccharides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Saponins; Sepsis; Triterpenes

2022
Astragaloside IV Protects Sepsis-induced Acute Kidney Injury by Attenuating Mitochondrial Dysfunction and Apoptosis in Renal Tubular Epithelial Cells.
    Current pharmaceutical design, 2022, Volume: 28, Issue:34

    Topics: Acute Kidney Injury; Animals; Apoptosis; Electron Transport Complex I; Epithelial Cells; Mice; Mitochondria; Saponins; Sepsis

2022
Astragaloside IV ameliorates sepsis-induced myocardial dysfunction by regulating NOX4/JNK/BAX pathway.
    Life sciences, 2022, Dec-01, Volume: 310

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Lipopolysaccharides; Myocytes, Cardiac; NADPH Oxidase 4; Rats; Rats, Sprague-Dawley; Saponins; Sepsis; Triterpenes

2022
Astragaloside IV alleviates sepsis-induced muscle atrophy by inhibiting the TGF-β1/Smad signaling pathway.
    International immunopharmacology, 2023, Volume: 115

    Topics: Animals; Mice; Muscular Atrophy; Quality of Life; Sepsis; Signal Transduction; Transforming Growth Factor beta1

2023
Astragaloside IV attenuates sepsis-induced intestinal barrier dysfunction via suppressing RhoA/NLRP3 inflammasome signaling.
    International immunopharmacology, 2020, Volume: 78

    Topics: ADP Ribose Transferases; Animals; Astragalus propinquus; Botulinum Toxins; Caco-2 Cells; Disease Models, Animal; Drugs, Chinese Herbal; Gene Knockdown Techniques; Humans; Inflammasomes; Injections, Intravenous; Intestinal Mucosa; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Permeability; rhoA GTP-Binding Protein; RNA, Small Interfering; Saponins; Sepsis; Signal Transduction; Triterpenes

2020
Astragaloside IV Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction in Rats via IKK/NF-κB Pathway.
    Chinese journal of integrative medicine, 2021, Volume: 27, Issue:11

    Topics: Animals; Disease Models, Animal; Heart Diseases; NF-kappa B; Rats; Rats, Sprague-Dawley; Saponins; Sepsis; Triterpenes; Tumor Necrosis Factor-alpha

2021
Astragaloside IV protects against polymicrobial sepsis through inhibiting inflammatory response and apoptosis of lymphocytes.
    The Journal of surgical research, 2016, Volume: 200, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Blotting, Western; Cytokines; Drugs, Chinese Herbal; Injections, Intravenous; Lymphocytes; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Phagocytes; Protective Agents; Random Allocation; Saponins; Sepsis; Triterpenes

2016